Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Per Ljungman

Karolinska University Hospital

Sweden

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

70%

Virology

90%

Hematology

80%

Transplantation

50%

Antiviral Therapy

40%

Immunotherapy

40%

Graft-versus-host Disease

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

The Stockholm early detection of cancer study (STEADY-CAN): rationale, design, data collection, and baseline characteristics for 2.7 million participants

Article Link

Year:

2025

Do not forget vaccinations in patients on Ig replacement

Article Link

Year:

2025

Author’s Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

Article Link

Year:

2025

Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10)

Article Link

Year:

2025

Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia

Article Link

Year:

2025

Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum

Article Link

Year:

2024

Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Article Link

Year:

2024

Vaccination of Adults With Cancer: ASCO Guideline

Article Link

Year:

2024

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy

Article Link

Year:

2024

Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT

Article Link

Year:

2024

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)

Article Link

Year:

2023

Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation Recipients

Article Link

Year:

2023

New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMT

Article Link

Year:

2023

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

Article Link

Year:

2022

The Importance of Secretor-Status in Norovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation

Article Link

Year:

2022

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)

Article Link

Year:

2022

Cancer incidence in healthy Swedish peripheral blood stem cell donors

Article Link

Year:

2022

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

Article Link

Year:

2022

Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study

Article Link

Year:

2022

Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT

Article Link

Year:

2022

Collaborators17

Grzegorz Władysław Basak

University Clinical Centre

POLAND

Rafael de la Camara

- Head of Haematology

Hospital Universitario Virgen del Rocío

SPAIN

Ibrahim Yakoub-Agha

Professeur des Universités - Praticien Hospitalier

Centre Hospitalier Régional Universitaire de Lille

FRANCE

Elinor Nemlander

Karolinska Institutet

SWEDEN

Hans H. Hirsch

SWITZERLAND

Gustaf Edgren

Karolinska Institutet

SWEDEN

Fareed Khawaja

Assistant professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Jan Styczyński

POLAND

MALGORZATA MIKULSKA

University of Genoa

ITALY

Jaime Sanz

Profesor asociado asistencial

Universidad Católica de Valencia Facultad de Medicina

SPAIN

Johan Richter

Professor

Lund University

SWEDEN

Michael J. Boeckh

University of Washington

UNITED STATES

Leif Stenke

SWEDEN

Diana Averbuch

ISRAEL

Achilles Anagnostopoulos

Chief Scientific Director

GREECE

Johan Nordgren

Linköping University

SWEDEN

Nina Worel

Medical University of Vienna

AUSTRIA

How do I reach out?

Meet Kite AI